Mirus, Fugent Settle Patent Litigation | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mirus Biosciences and Fugent have settled a lawsuit in which Mirus alleged Fugent infringed on a patent covering a method for gene transfer.

Fugent said in a statement today that the litigation was "resolved to Fugent's satisifaction and with no monetary compensation or other damages being paid by Fugent to Mirus." Mirus had asked for treble damages and attorney's fees in its complaint.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.